Skip to main content
. 2024 Sep 17;15:1445653. doi: 10.3389/fimmu.2024.1445653

Figure 2.

Figure 2

SARS-CoV-2–specific antibody titres and relationship with incident infection. (A) Significantly higher SARS-CoV-2–specific anti-RBD, anti-S1, and anti-S2 titres at day 14. *p ≤ 0.0001 compared to pre-vaccine response by Wilcoxon signed-rank test. (B) There was no significant difference in anti-RBD IgG, anti–spike-subunit-1 IgG, or anti–spike-subunit-2 IgG titres at day 14 in those who developed infection and those who did not develop infection. Bars represent median and interquartile range. P-values calculated by Mann–Whitney U test are shown above each comparison. D0, day 0; D14, day 14; RBD, receptor-binding domain; S, spike; S1, spike subunit 1; S2, spike subunit 2; BAU, binding antibody unit; IgG Immunoglobulin G.